Harnessing reactive oxygen species for advanced drug delivery and therapeutics
Journal of Controlled Release · 2026-12 · 400 · 115437
DOI: 10.1016/j.jconrel.2026.115437 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Controlled Release, 2026-12. Verfasst von Jae Hyung Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jhpark1@skku.edu. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Reactive oxygen species (ROS) have a unique position at the intersection of biology, chemistry, materials science, and medicine. They are indispensable mediators of physiological signalling, host defence, tissue remodelling, and cellular adaptation, yet their dysregulation is intimately associated with cancer, chronic inflammation, infection, metabolic disease, cardiovascular and cerebrovascular disorders, tissue injury, and ageing. This duality has made ROS both a therapeutic target and an attractive biological trigger for drug delivery. The Journal of Controlled Release Special Issue on "Harnessing Reactive Oxygen Species for Advanced Drug Delivery and Therapeutics" brings together a diverse collection of contributions that together present an important transition in the field. ROS-based delivery is moving beyond the conventional concept of a material that simply responds to an elevated oxidative environment. The contributions assembled here demonstrate that ROS can be scavenged, generated, amplified, buffered, spatially confined, chemically translated into drug release, coupled to immune modulation, integrated with metabolic sensing, and incorporated into theranostic and adaptive therapeutic systems.
Autor:innen und Institutionen
- School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jhpark1@skku.edu.
- Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX,…
- Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen (UMCG), University of Groningen, 9713 AV Groningen, The Netherlands. El…
Zitieren
APA
Park, J. H., Wang, A. Z., & Santos, H. A. (2026). Harnessing reactive oxygen species for advanced drug delivery and therapeutics. Journal of Controlled Release, 400, 115437. https://doi.org/10.1016/j.jconrel.2026.115437
Vancouver
Park JH, Wang AZ, Santos HA. Harnessing reactive oxygen species for advanced drug delivery and therapeutics. Journal of Controlled Release. 2026;400:115437. doi:10.1016/j.jconrel.2026.115437
BibTeX
@article{Park2026,
author = {Park, Jae Hyung and Wang, Andrew Z and Santos, Hélder A},
title = {Harnessing reactive oxygen species for advanced drug delivery and therapeutics},
journal = {Journal of Controlled Release},
year = {2026},
volume = {400},
pages = {115437},
doi = {10.1016/j.jconrel.2026.115437}
}
EUVIMED